Teva Pharmaceuticals, the world's largest generic drugmaker, saw its second-quarter revenue decline 18 percent to $4.7 billion — suggesting its financial woes have not passed, The Wall Street Journal reports.
Pharmacy
There is a new piece of hardware pharmaceutical CEOs can bring home — a trophy for being the "Most Hated Pharma CEO of the Year," according to a STAT newsletter.
AuroMedics Pharma has issued a nationwide recall of two lots of injectable Piperacillin and Tazobactam, a penicillin antibiotic used to treat pelvic infections, skin infections and hospital-acquired pneumonia.
Ranier's Rx Laboratory has issued a voluntary recall of all sterile compounded drug products distributed to hospitals and consumers.
Ian Read, Pfizer's CEO, believes the controversial rebates drugmakers pay to pharmacy benefit managers will soon vanish, according to STAT.
Pfizer, the largest drugmaker in the U.S., saw its second-quarter net income climb 26 percent to $3.87 billion, according to The Wall Street Journal.
In a move expected to save the health system $12 million, New Hyde Park, N.Y.-based Northwell Health will move its pharmacy and delivery service in-house for its 66,000 employees, according to a Newsday report.
CVS Health fired a pharmacist who would not fill a transgender woman's hormone prescription April 24 at a pharmacy in Phoenix, according to USA Today.
Medicare patients could often spend less on prescriptions filled through Walmart's generic drug discount program than through their own insurance plan, according to research from New Haven, Conn.-based Yale School of Medicine.
AstraZeneca will not raise the price of its medications in 2018, joining the ranks of numerous drug companies changing their pricing strategies after scrutiny from President Donald Trump, reports Reuters.